Donaldson Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $105M | Buy |
482,055
+3,418
| +0.7% | +$758K | 3.39% | 5 |
|
|
2025
Q4 | $109M | Sell |
478,637
-3,594
| -0.7% | -$819K | 3.48% | 7 |
|
|
2025
Q3 | $112M | Buy |
482,231
+4,744
| +1% | +$966K | 3.54% | 6 |
|
|
2025
Q2 | $88.6M | Sell |
477,487
-3,145
| -0.7% | -$584K | 3.25% | 7 |
|
|
2025
Q1 | $101M | Buy |
480,632
+10,896
| +2% | +$2.12M | 3.8% | 4 |
|
|
2024
Q4 | $83.5M | Buy |
469,736
+1,124
| +0.2% | +$207K | 3.19% | 6 |
|
|
2024
Q3 | $92.5M | Buy |
468,612
+3,643
| +0.8% | +$680K | 3.56% | 5 |
|
|
2024
Q2 | $79.8M | Sell |
464,969
-8,455
| -2% | -$1.4M | 3.35% | 6 |
|
|
2024
Q1 | $86.2M | Buy |
473,424
+2,224
| +0.5% | +$383K | 3.59% | 5 |
|
|
2023
Q4 | $73M | Sell |
471,200
-12,194
| -3% | -$1.78M | 3.27% | 6 |
|
|
2023
Q3 | $72.1M | Buy |
483,394
+5,417
| +1% | +$795K | 3.39% | 4 |
|
|
2023
Q2 | $64.4M | Buy |
477,977
+5,311
| +1% | +$779K | 2.94% | 7 |
|
|
2023
Q1 | $75.3M | Buy |
472,666
+2,896
| +0.6% | +$443K | 3.56% | 3 |
|
|
2022
Q4 | $75.9M | Buy |
469,770
+7,287
| +2% | +$1.12M | 3.7% | 3 |
|
|
2022
Q3 | $62.1M | Buy |
462,483
+5,233
| +1% | +$751K | 3.41% | 4 |
|
|
2022
Q2 | $70M | Sell |
457,250
-99,622
| -18% | -$15.2M | 3.6% | 3 |
|
|
2022
Q1 | $90.3M | Sell |
556,872
-436
| -0.1% | -$63.3K | 4.11% | 3 |
|
|
2021
Q4 | $75.5M | Buy |
557,308
+8,879
| +2% | +$1.05M | 3.32% | 6 |
|
|
2021
Q3 | $59.2M | Buy |
548,429
+6,756
| +1% | +$772K | 2.98% | 6 |
|
|
2021
Q2 | $61M | Buy |
541,673
+11,929
| +2% | +$1.34M | 3.12% | 4 |
|
|
2021
Q1 | $57.3M | Buy |
529,744
+7,936
| +2% | +$849K | 3.15% | 3 |
|
|
2020
Q4 | $55.9M | Sell |
521,808
-1,291
| -0.2% | -$124K | 3.31% | 4 |
|
|
2020
Q3 | $45.8M | Sell |
523,099
-11,217
| -2% | -$1.06M | 3.1% | 7 |
|
|
2020
Q2 | $52.5M | Buy |
534,316
+5,325
| +1% | +$469K | 3.81% | 3 |
|
|
2020
Q1 | $40.3M | Buy |
528,991
+35,961
| +7% | +$3.06M | 3.52% | 4 |
|
|
2019
Q4 | $43.7M | Buy |
493,030
+11,093
| +2% | +$921K | 2.95% | 5 |
|
|
2019
Q3 | $36.5M | Buy |
481,937
+100,832
| +26% | +$6.91M | 2.71% | 10 |
|
|
2019
Q2 | $27.7M | Buy |
381,105
+8,901
| +2% | +$700K | 2.3% | 24 |
|
|
2019
Q1 | $30M | Sell |
372,204
-20,431
| -5% | -$1.67M | 2.67% | 16 |
|
|
2018
Q4 | $36.2M | Buy |
392,635
+158
| +0% | +$13.9K | 3.69% | 3 |
|
|
2018
Q3 | $37.1M | Sell |
392,477
-1,246
| -0.3% | -$118K | 3.24% | 6 |
|
|
2018
Q2 | $36.5M | Sell |
393,723
-4,514
| -1% | -$441K | 3.56% | 4 |
|
|
2018
Q1 | $37.7M | Sell |
398,237
-12,812
| -3% | -$1.41M | 3.71% | 2 |
|
|
2017
Q4 | $39.8M | Sell |
411,049
-6,823
| -2% | -$643K | 3.88% | 1 |
|
|
2017
Q3 | $37.1M | Sell |
417,872
-1,059
| -0.3% | -$80.6K | 3.9% | 1 |
|
|
2017
Q2 | $30.4M | Sell |
418,931
-8,853
| -2% | -$595K | 3.44% | 4 |
|
|
2017
Q1 | $27.9M | Sell |
427,784
-8,646
| -2% | -$544K | 3.24% | 10 |
|
|
2016
Q4 | $27.3M | Buy |
436,430
+170
| +0% | +$10.4K | 3.36% | 4 |
|
|
2016
Q3 | $27.5M | Buy |
436,260
+9,040
| +2% | +$585K | 3.64% | 3 |
|
|
2016
Q2 | $26.4M | Buy |
427,220
+11,450
| +3% | +$698K | 3.67% | 3 |
|
|
2016
Q1 | $23.7M | Sell |
415,770
-2,985
| -0.7% | -$166K | 3.42% | 6 |
|
|
2015
Q4 | $24.8M | Buy |
418,755
+771
| +0.2% | +$44.4K | 3.63% | 4 |
|
|
2015
Q3 | $22.7M | Sell |
417,984
-722
| -0.2% | -$47K | 3.39% | 4 |
|
|
2015
Q2 | $28.1M | Buy |
418,706
+12,553
| +3% | +$820K | 4% | 1 |
|
|
2015
Q1 | $23.8M | Buy |
406,153
+68,271
| +20% | +$4.12M | 3.35% | 2 |
|
|
2014
Q4 | $22.1M | Sell |
337,882
-94
| -0% | -$5.93K | 3.3% | 7 |
|
|
2014
Q3 | $19.5M | Buy |
337,976
+11,704
| +4% | +$650K | 3.09% | 10 |
|
|
2014
Q2 | $18.4M | Buy |
326,272
+12,492
| +4% | +$655K | 2.95% | 8 |
|
|
2014
Q1 | $16.1M | Buy |
313,780
+10,930
| +4% | +$552K | 2.92% | 12 |
|
|
2013
Q4 | $16M | Buy |
302,850
+22,381
| +8% | +$1.1M | 3.09% | 10 |
|
|
2013
Q3 | $12.5M | Buy |
280,469
+2,698
| +1% | +$120K | 2.65% | 17 |
|
|
2013
Q2 | $11.5M | Buy |
+277,771
| New | +$12.1M | 2.6% | 20 |
|
Other funds holding ABBV
VCM
VPM
Donaldson Capital Management's ABBV Position: Q1 2026 in Review
Donaldson Capital Management increased its AbbVie (ABBV) stake by 0.71% in Q1 2026, buying an estimated $758K and bringing the position to 482,055 shares worth $105M. The position accounts for 3.39% of the portfolio, ranked #5.
Donaldson Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $112M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Donaldson Capital Management held 482,055 shares of AbbVie worth $105M as of Q1 2026.
- Donaldson Capital Management bought 3,418 AbbVie shares in Q1 2026, an estimated $758K.
- AbbVie made up 3.39% of Donaldson Capital Management's portfolio in Q1 2026, its #5 holding.
- Donaldson Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Donaldson Capital Management's AbbVie position peaked at $112M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.